A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.

Abstract:

OBJECTIVE:To assess whether exon deletions or duplications in CLCN1 are associated with recessive myotonia congenita (MC). METHODS:We performed detailed clinical and electrophysiologic characterization in 60 patients with phenotypes consistent with MC. DNA sequencing of CLCN1 followed by multiplex ligation-dependent probe amplification to screen for exon copy number variation was undertaken in all patients. RESULTS:Exon deletions or duplications in CLCN1 were identified in 6% of patients with MC. Half had heterozygous exonic rearrangements. The other 2 patients (50%), with severe disabling infantile onset myotonia, were identified with both a homozygous mutation, Pro744Thr, which functional electrophysiology studies suggested was nonpathogenic, and a triplication/homozygous duplication involving exons 8-14, suggesting an explanation for the severe phenotype. CONCLUSIONS:These data indicate that copy number variation in CLCN1 may be an important cause of recessive MC. Our observations suggest that it is important to check for exon deletions and duplications as part of the genetic analysis of patients with recessive MC, especially in patients in whom sequencing identifies no mutations or only a single recessive mutation. These results also indicate that additional, as yet unidentified, genetic mechanisms account for cases not currently explained by either CLCN1 point mutations or exonic deletions or duplications.

journal_name

Neurology

journal_title

Neurology

authors

Raja Rayan DL,Haworth A,Sud R,Matthews E,Fialho D,Burge J,Portaro S,Schorge S,Tuin K,Lunt P,McEntagart M,Toscano A,Davis MB,Hanna MG

doi

10.1212/WNL.0b013e318259e19c

subject

Has Abstract

pub_date

2012-06-12 00:00:00

pages

1953-8

issue

24

eissn

0028-3878

issn

1526-632X

pii

WNL.0b013e318259e19c

journal_volume

78

pub_type

杂志文章
  • Mitochondrial DNA alterations as a source of human disorders.

    abstract::The mitochondrial genome has an underdeveloped "DNA repair repertoire" compared with the nuclear genome, making the mitochondrial DNA more susceptible to mutations by endogenous factors such as defects of the mitochondrial polymerase itself, and by exogenous factors such as radiation and UV light. Increased sensitivit...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/wnl.43.2.280

    authors: Tritschler HJ,Medori R

    更新日期:1993-02-01 00:00:00

  • Effects of oral choline on human complex partial seizures.

    abstract::We carried out an open study of the effects of large doses (12 to 16 gm per day) of oral choline on medically intractable human complex partial seizures (CPS). Marked increases of plasma choline concentration (75 to 300%) in three subjects were associated with (1) shorter duration of CPS, (2) less postseizure fatigue,...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.30.12.1334

    authors: McNamara JO,Carwile S,Hope V,Luther J,Miller P

    更新日期:1980-12-01 00:00:00

  • Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: an overview.

    abstract::A number of unresolved issues complicate the effective management of patients with Parkinson's disease (PD). Chief among these is the role of neuroprotective versus symptomatic pharmacologic interventions. Until the etiology of PD is further defined, consensus on appropriate management of this illness is unlikely. Cli...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/wnl.49.1_suppl_1.s2

    authors: Stern MB

    更新日期:1997-07-01 00:00:00

  • Metabolic correlates of levodopa response in Parkinson's disease.

    abstract:OBJECTIVE:To assess the effects of levodopa on resting-state brain metabolism in PD. BACKGROUND:In previous studies the authors used [18F] fluorodeoxyglucose (FDG) and PET to quantify regional metabolic abnormalities in PD. They found that this disease is characterized reproducibly by a specific abnormal PD-related pa...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.57.11.2083

    authors: Feigin A,Fukuda M,Dhawan V,Przedborski S,Jackson-Lewis V,Mentis MJ,Moeller JR,Eidelberg D

    更新日期:2001-12-11 00:00:00

  • Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.

    abstract:OBJECTIVE:To determine whether droxidopa, an oral norepinephrine precursor, improves symptomatic neurogenic orthostatic hypotension (nOH). METHODS:Patients with symptomatic nOH due to Parkinson disease, multiple system atrophy, pure autonomic failure, or nondiabetic autonomic neuropathy underwent open-label droxidopa ...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1212/WNL.0000000000000615

    authors: Kaufmann H,Freeman R,Biaggioni I,Low P,Pedder S,Hewitt LA,Mauney J,Feirtag M,Mathias CJ,NOH301 Investigators.

    更新日期:2014-07-22 00:00:00

  • Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.

    abstract:BACKGROUND:Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the CNS. The goal of this study was to characterize the effects of natalizumab treatment on cytokine production and expression of acti...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3181a8266f

    authors: Kivisäkk P,Healy BC,Viglietta V,Quintana FJ,Hootstein MA,Weiner HL,Khoury SJ

    更新日期:2009-06-02 00:00:00

  • Brugada syndrome in spinal and bulbar muscular atrophy.

    abstract:OBJECTIVE:The aim of this study was to clarify myocardial involvement and its clinical implications in subjects with spinal and bulbar muscular atrophy (SBMA), a neuromuscular disease affecting both neuronal and nonneuronal tissues. METHODS:Two independent cardiologists evaluated ECGs from a total of 144 consecutive s...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000000434

    authors: Araki A,Katsuno M,Suzuki K,Banno H,Suga N,Hashizume A,Mano T,Hijikata Y,Nakatsuji H,Watanabe H,Yamamoto M,Makiyama T,Ohno S,Fukuyama M,Morimoto S,Horie M,Sobue G

    更新日期:2014-05-20 00:00:00

  • Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease.

    abstract:OBJECTIVES:To investigate capacity to consent to medical treatment (competency) in cognitively impaired patients with PD. BACKGROUND:Although competency has been studied empirically in patients with cortical dementia (AD), no empirical studies have examined competency in patients with PD or other subcortical neurodege...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.56.1.17

    authors: Dymek MP,Atchison P,Harrell L,Marson DC

    更新日期:2001-01-09 00:00:00

  • Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child

    abstract:OBJECTIVE:To evaluate published evidence of efficacy and safety of pharmacologic treatments for childhood spasticity due to cerebral palsy. METHODS:A multidisciplinary panel systematically reviewed relevant literature from 1966 to July 2008. RESULTS:For localized/segmental spasticity, botulinum toxin type A is establ...

    journal_title:Neurology

    pub_type: 杂志文章,实务指引,评审

    doi:10.1212/WNL.0b013e3181cbcd2f

    authors: Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.,Delgado MR,Hirtz D,Aisen M,Ashwal S,Fehlings DL,McLaughlin J,Morrison LA,Shrader MW,Tilton A,Vargus-Adams

    更新日期:2010-01-26 00:00:00

  • Short-chain fatty acids and encephalopathy of Reye's syndrome.

    abstract::Plasma levels of six short-chain fatty acids (SCFA) were measured in 23 Reye's syndrome patients. In sequential measurements, only propionic acid correlated closely with neurologic severity. Although admission SCFA levels were slightly elevated, there were no significant differences between patients grouped by severit...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.34.6.831

    authors: McArthur B,Sarnaik AP,Mitchell RA

    更新日期:1984-06-01 00:00:00

  • Temporal reorganization to overcome monocular demyelination.

    abstract:OBJECTIVE:To identify the source of delayed visual evoked potential (VEP) latencies in the fellow eyes of patients with optic neuritis (ON) and determine whether these latencies stem from clinically silent demyelination or reflect an adaptive process for synchronization with the affected eyes. METHODS:The study sample...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3182a1aa3e

    authors: Raz N,Chokron S,Ben-Hur T,Levin N

    更新日期:2013-08-20 00:00:00

  • Striatonigral degeneration: clinical, MRI, and pathologic correlation.

    abstract::We report a patient with striatonigral degeneration in whom T2-weighted MRI imaging revealed low signal and atrophy in the putamen. Neuropathologic studies confirmed putaminal atrophy and iron deposition in the MRI low signal regions. ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.40.4.710

    authors: O'Brien C,Sung JH,McGeachie RE,Lee MC

    更新日期:1990-04-01 00:00:00

  • Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.

    abstract::A 59-year-old woman with levodopa-responsive parkinsonism complicated by motor fluctuations and generalized levodopa dyskinesia underwent bilateral subthalamic deep brain stimulation (STN DBS) 7 years after symptom onset. DBS improved levodopa-responsive upper extremity bradykinesia but aggravated speech, swallowing, ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000073986.74883.36

    authors: Tarsy D,Apetauerova D,Ryan P,Norregaard T

    更新日期:2003-07-22 00:00:00

  • Pharmacokinetics, pharmacodynamics, and tolerability of tolcapone: a review of early studies in volunteers.

    abstract::Tolcapone is a potent, reversible inhibitor of catechol O-methyltransferase (COMT) intended for use as an adjunct to levodopa therapy for Parkinson's disease (PD). Findings from the first pharmacokinetics/pharmacodynamics and tolerability studies of tolcapone in volunteers are reviewed. Following linear and dose-propo...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/wnl.50.5_suppl_5.s31

    authors: Jorga KM

    更新日期:1998-05-01 00:00:00

  • Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.

    abstract:BACKGROUND:Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare multisystem disorder associated with plasma cell dyscrasia. There is increasing evidence that high-dose chemotherapy with autologous peripheral blood stem cell transplantation (Auto-PBSCT) is an efficacious t...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000323811.42080.a4

    authors: Kuwabara S,Misawa S,Kanai K,Suzuki Y,Kikkawa Y,Sawai S,Hattori T,Nishimura M,Nakaseko C

    更新日期:2008-11-18 00:00:00

  • Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.

    abstract::We performed magnetic resonance imaging (MRI), before and after the administration of gadolinium-DTPA (Gd-DTPA), in 23 patients with medically refractory partial epilepsy who subsequently had surgical treatment for their seizure disorder. In most patients, 61%, unenhanced and enhanced MRI studies were negative. In 26%...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.39.8.1115

    authors: Cascino GD,Hirschorn KA,Jack CR,Sharbrough FW

    更新日期:1989-08-01 00:00:00

  • Increased florbetapir binding in the temporal neocortex from age 20 to 60 years.

    abstract:OBJECTIVE:To improve our understanding of early β-amyloid (Aβ) accumulation processes using florbetapir-PET scan in 20- to 60-year-old individuals. METHODS:Seventy-six cognitively normal individuals aged 20 to 60 years, 57 cognitively normal older individuals (61-84 years old), and 70 patients with mild cognitive impa...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000004733

    authors: Gonneaud J,Arenaza-Urquijo EM,Mézenge F,Landeau B,Gaubert M,Bejanin A,de Flores R,Wirth M,Tomadesso C,Poisnel G,Abbas A,Desgranges B,Chételat G

    更新日期:2017-12-12 00:00:00

  • Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion.

    abstract::Spinocerebellar ataxia type 6 (SCA6) is a newly classified autosomal-dominant cerebellar ataxia (ADCA) associated with CAG repeat expansion. We screened 111 patients with cerebellar ataxia for the SCA6 mutation. Of these, 35 patients were found to have expanded CAG repeats in the SCA6 gene, indicating that second to S...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.49.5.1238

    authors: Matsumura R,Futamura N,Fujimoto Y,Yanagimoto S,Horikawa H,Suzumura A,Takayanagi T

    更新日期:1997-11-01 00:00:00

  • Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?

    abstract:OBJECTIVE:To examine metabolism during exercise in 2 patients with muscle phosphorylase kinase (PHK) deficiency and to further define the phenotype of this rare glycogen storage disease (GSD). METHODS:Patient 1 (39 years old) had mild exercise-induced forearm pain, and EMG showed a myopathic pattern. Patient 2 (69 yea...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e31824365f9

    authors: Preisler N,Orngreen MC,Echaniz-Laguna A,Laforet P,Lonsdorfer-Wolf E,Doutreleau S,Geny B,Akman HO,Dimauro S,Vissing J

    更新日期:2012-01-24 00:00:00

  • Rates and risk factors for progression to incident dementia vary by age in a population cohort.

    abstract:OBJECTIVE:To estimate rate of progression from normal cognition or mild impairment to dementia, and to identify potential risk and protective factors for incident dementia, based on age at dementia onset in a prospective study of a population-based cohort (n = 1,982) aged 65 years and older. METHODS:Following the coho...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000001113

    authors: Ganguli M,Lee CW,Snitz BE,Hughes TF,McDade E,Chang CC

    更新日期:2015-01-06 00:00:00

  • Long-term acetyl-L-carnitine treatment in Alzheimer's disease.

    abstract::In a double-blind, placebo-controlled, parallel-group, randomized clinical trial, we studied the efficacy of long-term (1-year) oral treatment with acetyl-L-carnitine in 130 patients with a clinical diagnosis of Alzheimer's disease. We employed 14 outcome measures to assess functional and cognitive impairment. After 1...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1212/wnl.41.11.1726

    authors: Spagnoli A,Lucca U,Menasce G,Bandera L,Cizza G,Forloni G,Tettamanti M,Frattura L,Tiraboschi P,Comelli M

    更新日期:1991-11-01 00:00:00

  • Rate and types of fractures in corticosteroid-treated multiple sclerosis patients.

    abstract::In a retrospective study of 103 corticosteroid-treated MS patients, the average rate of fracture events was 3.2% of the patients per year over 7.1 (+/- 5.7 SD) years at risk. Fractures of the ribs, pelvis, hip, or vertebrae occurred in 11 patients and became most common 5 years after starting steroids. Relatively high...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.42.7.1389

    authors: Troiano RA,Jotkowitz A,Cook SD,Bansil S,Zito G

    更新日期:1992-07-01 00:00:00

  • Twelve-month recovery of medical decision-making capacity following traumatic brain injury.

    abstract:OBJECTIVE:To investigate recovery of medical decision-making capacity (MDC) over the first year following traumatic brain injury (TBI). METHODS:A total of 177 participants (111 persons with TBI and 66 healthy controls) were recruited from an inpatient/outpatient TBI rehabilitation unit and outpatient neurology departm...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000003079

    authors: Steward KA,Gerstenecker A,Triebel KL,Kennedy R,Novack TA,Dreer LE,Marson DC

    更新日期:2016-09-06 00:00:00

  • Mineralization of the basal ganglia detected by CT in Hallervorden-Spatz syndrome.

    abstract::We studied a patient with autopsy-proven Hallervorden-Spatz syndrome (HSS) and the previously unreported finding of high-density lesions in the basal ganglia on CT. The diagnosis of HSS should be considered in a patient with dystonia and basal ganglia mineralization on CT. ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.38.1.154

    authors: Tennison MB,Bouldin TW,Whaley RA

    更新日期:1988-01-01 00:00:00

  • Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin.

    abstract::In multifocal motor neuropathy (MMN), little is known of the long-term effect of human immunoglobulin (HIG) infusions as a maintenance therapy. We report a patient who improved after an initial HIG infusion of 2 g/kg and continued to improve both clinically and electrophysiologically during maintenance HIG treatment c...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.45.5.987

    authors: Van den Berg LH,Franssen H,Wokke JH

    更新日期:1995-05-01 00:00:00

  • Current treatment pathways in ALS: a European perspective.

    abstract::This article presents the findings relating to the European subgroup of 91 patients in an international survey of the current diagnosis and treatment of patients with amyotrophic lateral sclerosis (ALS). The mean time between first symptoms and first consultation with a physician was 4.9 months, and mean delay in seei...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:

    authors: Dengler R

    更新日期:1999-01-01 00:00:00

  • Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.

    abstract:OBJECTIVE:To assess efficacy and safety of once-daily 8 or 12 mg perampanel, a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist, when added to concomitant antiepileptic drugs (AEDs) in the treatment of drug-resistant partial-onset seizures. METHODS:This was a multicenter,...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1212/WNL.0b013e3182635735

    authors: French JA,Krauss GL,Biton V,Squillacote D,Yang H,Laurenza A,Kumar D,Rogawski MA

    更新日期:2012-08-07 00:00:00

  • Normalization of brain serotonin by L-tryptophan in levodopa-treated rats.

    abstract::To test possible biochemical mechanisms by which L-tryptophan may reverse mental side effects of levodopa therapy in parkinsonism we administered levodopa, 250 mg per kilogram intraperitoneally, alone and with L-tryptophan, 500 mg per kilogram intraperitoneally, to rats pretreated with the peripheral dopa decarboxylas...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.25.9.861

    authors: Fahn S,Snider S,Prasad AL,Lane E,Makadon H

    更新日期:1975-09-01 00:00:00

  • Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

    abstract:OBJECTIVE:To assess the safety, tolerability, and biological activity of glial cell line-derived neurotrophic factor (GDNF) administered by an implanted intracerebroventricular (ICV) catheter and access port in advanced PD. BACKGROUND:GDNF is a peptide that promotes survival of dopamine neurons. It improved 6-OHDA- or...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1212/wnl.60.1.69

    authors: Nutt JG,Burchiel KJ,Comella CL,Jankovic J,Lang AE,Laws ER Jr,Lozano AM,Penn RD,Simpson RK Jr,Stacy M,Wooten GF,ICV GDNF Study Group. Implanted intracerebroventricular. Glial cell line-derived neurotrophic factor.

    更新日期:2003-01-14 00:00:00

  • Free light chains in multiple sclerosis and infections of the CNS.

    abstract::The intrathecal humoral immune response was analyzed in 83 patients with MS and 35 patients with acute CNS infections. CSF free kappa chains and CSF free lambda chains were quantified by radioimmunoassay; CSF IgG and albumin were measured by electroimmunodiffusion. The MS patients were characterized by higher levels o...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.37.8.1334

    authors: DeCarli C,Menegus MA,Rudick RA

    更新日期:1987-08-01 00:00:00